Efficacy of Low-Carbohydrate Ketogenic Diet in the Treatment of Type 2 Diabetes
- PMID: 33040057
- PMCID: PMC8280429
- DOI: 10.1159/000512142
Efficacy of Low-Carbohydrate Ketogenic Diet in the Treatment of Type 2 Diabetes
Abstract
Low-carbohydrate ketogenic diet (LCKD), originally used as a treatment for childhood epilepsy is currently gaining acceptance as a nutritional therapy for obesity and type 2 diabetes. In addition, this diet has a positive effect on body weight, blood glucose level, glycosylated hemoglobin, plasma lipid profile, and neurological disorders. This review focuses on the therapeutic effectiveness, negative effects, and the rationale of using LCKD for the treatment of type 2 diabetes. It is shown that LCKD contributes to the reduction in the intake of insulin and oral antidiabetic drugs in patients with type 2 diabetes. Furthermore, the data presented in this review reveal the efficacy and cost-effectiveness of LCKD in the management of type 2 diabetes.
Keywords: HbA1c; Low-carbohydrate ketogenic diet; Obesity; Type 2 diabetes.
© 2020 The Author(s) Published by S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
References
-
- Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. s.l: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2011.
-
- International Diabetes Federation . IDF diabetes atlas. 8th ed. Brussels, Belgium: International Diabetes Federation; 2017. Available online: http://www.diabetesatlas.org. - PubMed
-
- Fong DS, Aiello LP, Ferris FL, 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27((10)):2540–53. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
